What is the long-term trend for Bruker's payment for (proceeds from) other investing activity?

Over 2 years (2023 to 2025), Bruker's payment for (proceeds from) other investing activity has grown at a -61.5% compound annual growth rate (CAGR), from -$32.3M to -$4.8M.

Bruker BRKR Payment for (Proceeds from) Other Investing Activity

Payment for (Proceeds from) Other Investing Activity at other companies

Thermo Fisher ScientificTMO

——

DanaherDHR

——

GE HealthCare TechnologiesGEHC

——

IDEXIEX

——

Mettler-Toledo International, Inc.MTD

——

Charles River LaboratoriesCRL

——

Other financials

Income statement

See full

Revenue$823.4M+2.7%

Gross profit$379.8M-2.9%

Operating income$10.2M-67.9%

Net income$14.4M-17.2%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$137.6M-26.7%

Total debt$1.7B-20.9%

Total equity$2.5B+34.6%

Total assets$6.1B+3.3%

Cash flow

See full

Operating cash flow$71.2M+9.5%

CapEx$24.2M-6.9%

Free cash flow$47.0M+20.5%

Valuation

See full

Market cap$8.71B-13.2%

Enterprise value$10.25B-14.9%

P/S2.5×-0.4×

Profitability

See full

Gross margin45.3%-3.7pp

Operating margin1.3%-5.0pp

Net margin-0.6%-10.0pp

FCF margin1.5%-3.6pp

Returns & leverage

See full

Return on equity-1%-21.2pp

Debt / equity0.7×-0.5×

Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's payment for (proceeds from) other investing activity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bruker's payment for (proceeds from) other investing activity?: Bruker (BRKR) reported payment for (proceeds from) other investing activity of -$500K in Q1 2026.
How has Bruker's payment for (proceeds from) other investing activity changed year-over-year?: Bruker's payment for (proceeds from) other investing activity increased by 50.0% year-over-year, from -$1M to -$500K.
What is the long-term trend for Bruker's payment for (proceeds from) other investing activity?: Over 2 years (2023 to 2025), Bruker's payment for (proceeds from) other investing activity has grown at a -61.5% compound annual growth rate (CAGR), from -$32.3M to -$4.8M.